Blood biomarkers in ALS: challenges, applications and novel frontiers - PMC
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. 1 Centre of Neuroscience, Surgery and Trauma, Queen Mary University of London, London UK 1 Centre of Neuroscience, Surgery and Trauma, Queen Mary University of London, London UK 2 Queen Square Institute of Neurology, University College London, London UK Data sharing not applicable as no datasets were generated or analysed for the writing of this article Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease among adults.
Acta Neurol Scand . 2022 Sep 26;146(4):375–388. doi: 10.1111/ane.13698 Blood biomarkers in ALS: challenges, applications and novel frontiers Ellie Sturmey Ellie Sturmey 1 Centre of Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK Find articles by Ellie Sturmey 1, ✉ , Andrea Malaspina Andrea Malaspina 1 Centre of Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK 2 Queen Square Institute of Neurology, University College London, London, UK Find articles by Andrea Malaspina 1, 2, ✉ Author information Article notes Copyright and License infor
Explore this link on the map →related reading
- ALS - Wikipediaen.wikipedia.org
- Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status - PMCncbi.nlm.nih.gov
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? - PubMedpubmed.ncbi.nlm.nih.gov
- Biomarkers for Parkinson’s Disease: How Good Are They? - PMCpmc.ncbi.nlm.nih.gov
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Research Areas - Svendsen Lab | Cedars-Sinaicedars-sinai.edu
- Gap Mapgap-map.org
- Dying Outside — LessWronglesswrong.com
- Was a Mushroom Behind an ALS Outbreak in the Alps? - The Atlantictheatlantic.com
- Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research | Metabolic Brain Disease | Springer Nature Linklink.springer.com
- Amyloidosis - Symptoms, Causes, Treatment | NORDrarediseases.org